Prescription Medicines and Research Materials: Important Distinctions
A scientific name, a published study, and a certificate of analysis describe different things. None of them, by itself, makes a research catalog item an approved medicine.
Medicine approval is product-specific
The FDA reviews evidence supporting a drug application, including safety, effectiveness, manufacturing, and labeling. Approval of a particular medicine does not transfer to another supplier’s material because it has a similar name or references the same molecule.
What research records can establish
- A publication describes the material, methods, and results of that particular study. It does not certify an unrelated supplier or batch.
- A catalog record identifies the supplier’s item and available options. It is not prescribing information.
- A lot COA reports the tests and results documented for a particular sample. It does not establish clinical safety, effectiveness, or approval.
Research labels are not a substitute for authorization
The FDA explains that unapproved prescription drugs have not been reviewed for safety, effectiveness, or quality. A research label does not make a catalog material an approved medicine or establish its safety for human use. BioPep USA research materials must not be used as substitutes for prescribed medicines.
Documentation by catalog label
- 1-SM Single Agonist documentation
- 2-TRZ Double Agonist documentation
- 3-RTA Triple Agonist documentation
- Lot COA library
Official references
Last source review: September 29, 2026.
